Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

about

Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production.Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.

P2860

Q52720869-F75F4F62-4799-4C64-81E9-92476E864027 Q55007427-765692FF-D830-4EFC-B612-31C0498555B6

P2860

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q50130748

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@en

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@nl

type

Item

label

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@en

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@nl

prefLabel

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@en

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@nl

P1476

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

@en

P2093

Peter R Dodd

http://www.w3.org/2001/XMLSchema#string

Rakesh N Veedu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Evidence for natural antisense transcript-mediated inhibition of microRNA function

Inhibition of microRNA function by antimiR oligonucleotides

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

Tau pathology in Alzheimer disease and other tauopathies

Tauopathies

Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

P304

3933-3947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.7150/THNO.21529

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Madhuri Chakravarthy

Suxiang Chen

P5008

ScienceSource

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29109789

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5667416

http://www.w3.org/2001/XMLSchema#string

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

about

P2860

P2860

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932